SAR439859, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Antitumor Efficacy and Limited Cross-Resistance in ER+ Breast CancerMonsif Bouaboula,Maysoun Shomali,Jane Cheng,Natalia Malkova,Fangxian Sun,Malvika Koundinya,Zhuyan Guo,Stephane Poirier,Mikhail Levit,Dietmar Hoffman,Hui Cao,Laurent Bestret,Francisco Adrian,Christoph Winter,Youssef El-Ahmad,Sylvie Vincent,Frank Halley,Gary McCort,Laurent Schio,Vicky Richon,Hong Cheng,Karl Hsu,Chris Soria,Patrick Cohen,Joanne Lager,Carlos Garcia-Echeverria,Laurent DebusscheCANCER RESEARCH（2018）引用 10|浏览24关键词Breast CancerAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
